Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Touyun Biotech GroupHKSE:01332 -3.13%25 Gross Margin % is 171.13% as of Dec. 2025, which is 360% above its 10-year median of 37.19. GuruFocus rates HKSE:01332 with a GF Score™ of 25/100 and a GF Value™ of HK$0.16 (Fairly Valued). The stock has 6 warning signs investors should review. Among 383 Packaging & Containers companies, Touyun Biotech Group ranks better than 99.74% on this metric.
The historical rank and industry rank for Touyun Biotech Group's Gross Margin % or its related term are showing as below:
HKSE:01332'
s Gross Margin % Range Over the Past 10 Years
Min: -715.24 Med: 37.19 Max: 1084.21
Current: 1084.21
During the past 13 years, the highestGross Margin % of Touyun Biotech Group was 1084.21%. The lowest was -715.24%. And the median was 37.19%.
HKSE:01332's Gross Margin % is ranked better than 99.74% of 383
companies
in the Packaging & Containers industry
Industry Median: 21.48
vs HKSE:01332: 1084.21
Touyun Biotech Group had a gross margin of 171.13% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Touyun Biotech Group was 0.00% per year.
Touyun Biotech Group (HKSE:01332) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Touyun Biotech Group had a gross margin of 171.13% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Touyun Biotech Group Gross Margin % Related Terms
Touyun Biotech Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01332 vs SW, PKG, IP: Gross Margin % Comparison
For the Packaging & Containers subindustry, Touyun Biotech Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group Gross Margin % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Touyun Biotech Group (HKSE:01332) has a Gross Margin % of 171.13% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Touyun Biotech Group and its competitors. This is 360% above median its historical median of 37.19. According to the industry distribution chart, Touyun Biotech Group ranks #1 out of 383 companies in the Packaging & Containers industry, placing it in the top 0.3%.
Is Touyun Biotech Group's Gross Margin % too high?
Touyun Biotech Group's current Gross Margin % of 171.13% is 360% above median its 10-year median of 37.19. The Packaging & Containers industry median Gross Margin % is 21.48. Touyun Biotech Group's value of 171.13% is 696.7% above this industry median. Based on the distribution chart, Touyun Biotech Group ranks #1 out of 383 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Gross Margin % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #1 out of 383 companies for Gross Margin %. This places Touyun Biotech Group in the top 0% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 21.48. Touyun Biotech Group's value of 171.13% is 696.7% above this benchmark. While the company's 10-year median is 37.19 vs. the industry median of 21.48, Touyun Biotech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Packaging & Containers company?
The median Gross Margin % among Packaging & Containers companies is 21.48, based on 383 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touyun Biotech Group's current Gross Margin % of 171.13% is 696.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median Gross Margin % is 21.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current Gross Margin % is 171.13%, which is 360% above median its own 10-year median of 37.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.16 — trading 3.1% below its estimated fair value. The current Gross Margin % is 171.13%, which is 360% above median its 10-year median of 37.19 and 696.7% above the Packaging & Containers industry median of 21.48. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Gross Margin % is 171.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.16 is trading 3.1% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Fairly Valued.
Key valuation signals for HKSE:01332:
Gross Margin %: 171.13% (360% above median its 10-year median of 37.19)
GF Value™: HK$0.16 vs. price of HK$0.16 (3.1% below fair value)
Industry Position: 696.7% above the Packaging & Containers median (#1 of 383)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score
Get the complete analysis for HKSE:01332
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
